This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

PHER working group meeting agendas

From HL7Wiki
Revision as of 18:35, 24 August 2006 by Altamore (talk | contribs) (Agenda modified)
Jump to navigation Jump to search

[PHER main page]


PHER SIG Agenda - working group meeting Boca Raton September 10-15, 2006

Updated Monday August 21

Sunday, 9/10

  • No meeting

Monday, 9/11

Q1

  • HL7 plenary

Q2

  • HL7 plenary

Q3

  • Introductions
  • Approval of minutes from May 2006 - Rita Altamore
  • Review and approval of agenda
  • Update: harmonization - Jim Case
  • New harmonization proposals - Jim Case

Q4

  • Joint with Pt Safety
  • PHER TC proposal and realignment of PSSIG under PHER

Tuesday, 9/12

Q1

  • Immunization harmonization

Q2

  • RCRIM HOST - joint session with Pt Safety, PHER
  • DAM/BRIDG/Adverse event

Q3

  • OO HOST - joint session with PHARM, PHER, Pt Safety
  • BTOs, Immunizations and other items related to Medication DMIM & Clinical Statements
    • Harmonization with GIN/ICSR

Q4

  • Canadian PH messaging
    • PORR DMIM and CMETs

Wednesday, 9/13

Q1

  • Canadian PH messaging

Q2

  • Canadian PH messaging
    • Approaches to messaging clinical content

Q3

  • Co-chair elections - MOVED TO Thurs Q3
  • Patient Care HOST - joint session with PHER, Pharm, Pt Safety
  • Adverse events, allergy and exposure model

Q4

  • CA case transfer – Nancy McQuillen

Thursday, 9/14

Q1

  • Ballot reconciliation
    • CMET/Canadian dynamic model

Q2

  • Ballot reconciliation
    • CMET/Canadian dynamic model

Q3

  • Co-chair elections
  • Ballot reconciliation
    • CMET/Canadian dynamic model
  • Tooling

Q4

  • Ballot reconciliation
    • CMET/Canadian dynamic model
  • HITSP use of CDA for biosurveillance

Friday 9/15

Q1

  • Harmonization proposals (if time needed)- Jim Case
  • TB messaging - Anita Walden


Q2

  • Emergency response - Ed Hammond
  • New business
    • Fourth co-chair?
  • Agenda for next time
  • Adjournment

Q3

  • No meeting

Q4

  • No meeting